Zantac Alternative Drugs Recommended By The FDA May Cause Memory Loss

The side effects of protein pump inhibitor drugs may include temporary or permanent memory loss

Tuesday, October 27, 2020 - The latest and greatest problem that plagues protein pump inhibitor drugs is patient memory loss. Researchers are unclear whether or not the memory loss is temporary as studies have only been performed in the short term. Clinical trials at Ohio State University by Clinical Psychology Researcher Annelise Madison discovered, "memory problems were between 20% and 29% more severe than those reported by patients who didn't use PPI's," according to WQAD8.com, a news station in Davenport, Iowa. The implication is that the longer one uses PPIs the more severe and long-lasting memory loss could be. Zantac stomach cancer lawsuit attorneys offer a free no obligation consultation to families and people that developed stomach cancer from taking the antacid Zantac.

The US Food and Drug Administration (FDA) initially recommended that people stop taking Zantac (ranitidine), an H2 histamine blocker, and switch to another class of drugs called protein pump inhibitors (PPIs). The best selling PPI drugs include brand names Prilosec, Prevacid, and Nexium. These drugs did not test positive, unlike Zantac, for elevated levels of a cancer-causing substance called N-Nitrosodimethylamine (NDMA), and are still on the market.

NDMA is a carcinogenic byproduct of industrial production commonly found in low levels in the air, land, and water. Online drug testing pharmacy Valisure tested Zantac and found levels of NDMA over 1 million nanograms (ngs) per capsule, far exceeding the FDA guidelines of 96 ngs. Valisure immediately reported their findings to the FDA prompting Sanofi, the maker of Zantac to recall the world's best selling anti-heartburn and acid reflux medicine. The FDA recalled all ranitidine products about a month later.

PPI drugs have a long list of side effects, not the least of which is contributing to type-2 diabetes. A British medical journal has linked the long-term use of Protein Pump Inhibitors to an increased risk of developing Type-2 diabetes.

According to Diabetes In Control.com, "long-term PPI users (>2 years) have a 24% higher risk of developing diabetes compared to non-PPI users," according to the BMJ. Also, PPI drugs (may cause) other medical problems including, "... an increased risk of bone fractures, chronic kidney disease, gut infections such as C. difficile, vitamin B12 deficiency, and stomach cancer."

Zantac was recalled by the FDA earlier in 2020 due to finding accelerated levels of NDMA many thousands of times greater than the level thought to be safe. The FDA recommended the switch to PPI drugs, but those drugs are quickly turning out to have life-threatening problems of their own. The FDA is now caught between a rock and a hard place because to recall PPI drugs would mean that heartburn and acid reflux sufferers would have nothing to turn to besides living a more healthy lifestyle to try and curb their indigestion. Individuals have developed a variety of cancer allegedly from taking Zantac like stomach, bladder, esophagus, prostate, and breast cancer. Many have hired Zantac cancer lawyers to help them file a claim against Sanofi for failing to warn them of the health consequences of the medicine.

More Recent Heartburn MedicineLawsuit News:

• The FDA Suspects Zantac Could Contain Five More Cancer-Causing Impurities | 3/6/2021
• The Department of Justice Points To a 1983 Study That Found Accelerated Levels of NDMA in ranitidine | 3/3/2021
• Zantac Remains Off Of Store Shelves More Than A Year After NDMA Contamination Was Discovered | 3/2/2021
• Vitamins Can Help Regulate Stomach Acid | 2/27/2021
• Online Pharmacy Can Fill Prescriptions After Testing Your Drugs For Purity and Safety | 2/22/2021
• Walmart And CVS Are Co-Defendants in Ranitidine (Zantac) Cancer Lawsuits | 2/17/2021
• More Ways To Alleviate Heartburn Pain With Zantac No Longer Available | 2/16/2021
• Gradual Lifestyle Changes Can Cure Heartburn And Acid Reflux Disease | 2/15/2021
• Purity Certification May Have To Be Met If Zantac Could Ever Be Sold Again | 2/10/2021
• Zantac Alternatives May Cause Serious Diseases | 2/9/2021
• Constant Use of Heartburn and Acid Reflux Drugs Like Zantac Could Double Cancer Risks | 2/5/2021
• Ranitidine Is Unstable According to Valisure | 2/2/2021
• Heartburn Sufferers Look To PPI Drugs To Control Acid Reflux Disease and GERD | 2/1/2021
• California Zantac Plaintiffs Want State Court To Hear Their Cases | 1/29/2021
• Zantac Cancer Issues Are Affecting People In Europe, Canada, and The United States | 1/28/2021
• Former Zantac Users Need To Exercise a Little Common Sense | 1/27/2021
• The FDA Did Not Follow-Up Test Zantac Until Too Late | 1/25/2021
• Estates of the Desceased Can File a Zantac Cancer Lawsuit | 1/21/2021
• Zantac Cancer Prompts FDA To Seek Answers | 1/20/2021
• People May Be Exposed To NDMA From Many Sources | 1/19/2021
• Valisure CEO Infers Ranitidine (Zantac) May Be Unstable And Degrade On Its Own | 1/18/2021
• The Types of Zantac Cancer Identified In Multidistrict Litigation | 1/13/2021
• Zantac Cancer Trials Consolidated In Federal Court | 1/10/2021
• Facts About Filing A Zantac Cancer Lawsuit | 1/8/2021
• Zantac Cancer Claims Organized In Florida Multi-District Litigation | 1/6/2021
• Sanofi Could Be Guilty Of Failing To Disclose the potential presence of N-Nitrosodimethylamine (NDMA) in Zantac | 1/5/2021
• Ranitidine Zantac Cancer Will Make Headlines in 2021 | 1/4/2021
• FDA Recall of Zantac Ranks As One Of The Most Important Human Health Developments of 2020 | 12/28/2020
• Zantac Users May Require Surgery To Repair A Valve In Their Esophagus | 12/23/2020
• Study Finds Ranitidine (Zantac) May Be Inherently Unstable | 12/21/2020
• CEO Testimony May Implicate China As The Source Of Zantac NDMA Contamination | 12/16/2020
• Lockdowns Are Causing Obesity Heartburn Medicines Are In Short Supply | 12/14/2020
• Zantac And Ranitidine Are Recalled And The Alternatives Are In Short Supply | 12/11/2020
• Potential Zantac Cancer Plaintiffs Should Organize Their Documents | 12/9/2020
• Zantac Lawsuits Point To An Array of Negligence By Sanofi | 12/7/2020
• Ranitidine Could Be Back On The Market In Canada If The Manufacturer Meets Certain Conditions | 12/4/2020
• Scientific Experts Hired By Plaintiffs May Uncover The Reason Zantac Allegedly Causes Cancer | 12/1/2020
• November Review of Important Zantac Cancer Developments | 11/25/2020
• Advice For Former Zantac Patients Now That The Heartburn Drug Is No Longer Available | 11/23/2020
• Potential Zantac Plaintiffs Must Provide A Record Of Using The Medine | 11/19/2020
• Nitrates Suspected To Have Caused Zantac Contamination | 11/18/2020
• Military Veterans May Be Developing More Zantac Cancer Than The General Population | 11/17/2020
• The Failure To Oversee Chinese Drug Manufacturing May Have Led To Zantac Cancer Contamination | 11/16/2020
• Surviving Spouses And The Children of Those Who Have Died From Cancer Are Filing Zantac Cancer Lawsuits | 11/10/2020
• Heartburn Management Centers Seek To Capitalize on Zantac Ban | 11/7/2020
• Recalls Accelerating For Heartburn, Blood Pressure, and Type 2 Diabetes Drugs Over Cancer Fears | 11/4/2020
• China And India Could Be The Source of Zantac Contamination | 11/2/2020
• Sanofi Under Criminal Investigation By The US Department of Justice For False Claims Act Violations | 10/29/2020
• Scientists Focus On India And China As Source of Zantac Contamination | 10/26/2020
• Zantac May Cause Type-2 Diabetes As Well As Many Types of Cancer | 10/21/2020
• Discovery Proceeding in Zantac Cancer Litigation | 10/20/2020
• Heartburn Drug Manufacturer Sanofi Could Be Forced To Regularly Test Zantac For Carcinogens | 10/16/2020
• Researchers Continue to Struggle To Determine Why Zantac Could Cause Cancer | 10/12/2020
• Popular Zantac Alternative Drugs May Cause Type-2 Diabetes | 10/10/2020
• Tens Of Millions of Zantac Users May Develop Cancer | 10/7/2020
• Online Medical Experts Offer Advice On Dealing With Zantac Recall | 10/6/2020
• Sanofi May Have Known For Years That Zantac Could Cause Cancer | 10/5/2020
• Thousands of Former Zantac User Fear Cancer Diagnosis in Their Future | 10/1/2020
• Stomach Cancer Could Have Been Easily Treatable If Sanofi Warned of Zantac Cancer Sooner | 9/30/2020
• Administrative Procedures Organized in Lawsuits That Claim Zantac Caused Cancer | 9/28/2020
• Sanofi May Have Had An Obligation To Know That Zantac Could Cause Cancer | 9/24/2020
• Taking Zantac Was An Elective Decision Not A Medical Necessity | 9/23/2020
• Many Zantac Users Fear Stomach Cancer From Taking The Drug | 9/22/2020
• Many Zantac Users Fear Stomach Cancer From Taking The Drug | 9/21/2020
• Millions Were Left With Heartburn and Acid-Reflux Pain When Ranitidine (Zantac) Was Recalled | 9/17/2020
• Zantac Patients Are Advised Not To Abuse Their New PPI Drugs | 9/15/2020
• Plaintiffs Blame Zantac For Causing Colon Cancer | 9/14/2020
• Government Health Officials in The US and Canada Worry Zantac Cancer Could Affect Millions | 9/9/2020
• Zantac Prostate Cancer Has Men That Used Zantac Worried | 9/7/2020
• Zantac Cancer Contamination Could Occur In the Body | 8/31/2020
• Zantac Users Have Alternative Treatments That Diabetics and Others May Not | 8/29/2020
• Zantac Users Patiently Await Answers About Zantac Cancer | 8/26/2020
• Studies Find NDMA Increases For More Reasons Than High Temperatures Alone | 8/24/2020
• Understanding The Science of Zantac Breast Cancer | 8/15/2020
• Previous Zantac Users Should Make Lifestyle Changes | 8/12/2020
• Women Are Alarmed That Zantac May Cause Breast Cancer | 8/11/2020
• Removing Zantac From The Market Could Lead To People Developing Esophageal Cancer | 8/10/2020
• Alternative FDA Testing Methods Did Not Find Zantac To Be Dangerous | 8/6/2020
• An Online Testing Pharmacy May Have Jumped The Gun When Reporting Dangerous NDMA Levels | 8/5/2020
• Valisure's Testing Methods May Be Flawed And The Cause Of The Spike in NDMA | 8/3/2020
• Experts Are Trying To Understand NDMA | 7/31/2020
• Online Testing Pharmacy May Have Saved Millions From Zantac Cancer | 7/30/2020
• The FDA Falls Short in Zantac Cancer Testing | 7/28/2020
• Zantac Cancer May Be America's Next Public Health Crisis | 7/22/2020
• Cancer's Latency Could Drive Zantac Cancer Claims For Years | 7/20/2020
• Online Experts Warn Of The Dangers of Developing Zantac Cancer | 7/14/2020
• Zantac and Generic Ranitidine Heartburn Medicine Recalled Because of Cancer Link | 7/13/2020
• Former Zantac Users Have Few Options Left Other Than Adopting a Healthy Lifestyle | 7/10/2020
• Zantac Alternative Medicines May Increase The Risk of Contracting The Coronavirus | 7/8/2020
• Cases Are Being Consolidated Against Sanofi By Alleged Zantac Cancer Sufferers | 7/7/2020
• Zantac Users Should Consider Safer Alternative Drugs | 7/1/2020
• Nitrosamines NDMA Levels in Zantac Found To Be Thousands of Time Higher Than Acceptable | 6/30/2020
• The Zantac Cancer Scare Is Leading To Other Drug Recalls Throughout North America | 6/29/2020
• The Legal Process Has Started To Grind Against Heartburn Drug Manufacturers and Others | 6/24/2020
• Zantac Users Left Without Heartburn Medication By The Drugs Recalls | 6/22/2020
• Updated Guidance From The FDA Regarding Ranitidine, Zantac | 6/18/2020
• Diabetic Patients That Stop Taking Metformin Could Face Serious Health Complications | 6/16/2020
• Canada Follow The US And Recalls Several Diabetes Medications Over Cancer Risk | 6/15/2020
• It Has Been One Year Since Researchers Found a Carcinogen In Blood Pressure Medicine | 6/11/2020
• Finding Cancer Causing Chemicals in Heartburn Drugs Like Zantac May Be Only The Beginning | 6/10/2020
• Every Day Another Company Recalls Their Blood Pressure, Heartburn, or Diabetes Drug Due to Cancer Concerns | 6/8/2020
• Zantac Cancer May Be The Impetus Needed To Bring The US Drug Manufacturing Supply Chain Home | 6/5/2020
• Heartburn, Diabetes, and Blood Pressure Drugs May Contain Dangerously High Levels of a Carcinogen Called NDMA | 6/4/2020
• The FDA Is Forcing Some Diabetic Drug Manufacturers to Pull Their Type 2 Products From Store Shelves | 6/1/2020
• The FDA May Require Stricter Regulation of Foreign Drug Manufacturers | 5/29/2020
• Former Zantac Users Should Watch For Gastro-Intestinal Cancer Symptoms | 5/28/2020
• Lawsuits Continue To Be Filed Claiming Zantac Causes Cancer | 5/26/2020
• Global Concerns Over Zantac Cancer | 5/19/2020
• Breast Cancer Is The Latest Disease Allegedly Caused By Zantac | 5/18/2020
• Medical Expert Opinions Are Mixed About Zantac Being Carcinogenic | 5/12/2020
• Pepcid Anti-Heartburn Drug Sought To Treat Covid19 | 5/8/2020
• Heartburn Drugs May Be In Short Supply At Local Pharmacy | 5/6/2020
• FDA Recommended Heartburn Drugs May Cause Kidney Failure and Osteoperosis | 5/5/2020
• Zantac Users May Want to be Checked For Gastro-Intestinal Cancers | 5/1/2020
• Despite Zantac's Recall Other Antacid Medication Offer Promise To Help Alleviate COVID19 | 4/28/2020
• Zantac is Blamed For Causing Gastric Cancer | 4/23/2020
• Zantac Users Should Hold On To or Mail Back Unused Portions Instead Of Physically Returning The Drug | 4/20/2020
• Expert Advice For Previously Heavy Zantac Users | 4/16/2020
• Making Simple Dietary Changes Can Replace The Need For Antacids | 4/15/2020
• Lawsuit Alleges Zantac Caused Plaintiff's Colon Cancer | 4/13/2020
• Cancer-Causing Compound Leads to Diabetes Drug Recalls | 4/10/2020
• Lawsuits Are Being Considered By Heartburn Drug Cancer Victims | 4/9/2020
• Lawsuits Have Been Filed After Tests Show Triple the Allowable Levels of NDMA in Antacid drugs | 4/8/2020
• Popular Over-The-Counter Heartburn Pills May Cause Stomach Cancer | 4/7/2020
• Popular Anti-acid Drugs May Contain a Compound That is Proven To Cause Cancer | 4/6/2020

Lawyers for Zantac Heartburn Medicine Lawsuits

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The Onder Law Firm has won more than $300 million in four talcum powder ovarian cancer lawsuits in St. Louis. Law firms throughout the nation often seek its experience and expertise on complex litigation.